Literature DB >> 18219546

Case report: multiple fractures in a patient with mutations of TWIST1 and TNSALP.

Florian Barvencik1, Matthias Gebauer, Thorsten Schinke, Michael Amling.   

Abstract

Hypophosphatasia is a rare inherited disorder characterized by defective skeletal mineralization and low alkaline phosphatase activities in the serum. The genetic cause of hypophosphatasia is believed related to inactivating mutations in the TNSALP gene, encoding tissue-nonspecific alkaline phosphatase. Another rare inheritable disease, Saethre-Chotzen syndrome, leads to premature fusion of the cranial sutures caused by heterozygous mutations of the human TWIST1 gene. Because the two disorders apparently are not genetically related (only reported individually) yet both involve defective skeletal formation, we believe it is important to report our findings on a patient harboring mutations of TNSALP and TWIST1.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18219546      PMCID: PMC2504648          DOI: 10.1007/s11999-008-0123-9

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  21 in total

Review 1.  Control of osteoblast function and regulation of bone mass.

Authors:  Shun-ichi Harada; Gideon A Rodan
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

Review 2.  Genetic disorders of the skeleton: a developmental approach.

Authors:  Uwe Kornak; Stefan Mundlos
Journal:  Am J Hum Genet       Date:  2003-07-31       Impact factor: 11.025

3.  Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: formal histomorphometric and biomechanical analyses.

Authors:  M Amling; M Priemel; T Holzmann; K Chapin; J M Rueger; R Baron; M B Demay
Journal:  Endocrinology       Date:  1999-11       Impact factor: 4.736

4.  A survey of TWIST for mutations in craniosynostosis reveals a variable length polyglycine tract in asymptomatic individuals.

Authors:  N Elanko; J S Sibbring; K A Metcalfe; J Clayton-Smith; D Donnai; I K Temple; S A Wall; A O Wilkie
Journal:  Hum Mutat       Date:  2001-12       Impact factor: 4.878

5.  Structural evidence for a functional role of human tissue nonspecific alkaline phosphatase in bone mineralization.

Authors:  E Mornet; E Stura; A S Lia-Baldini; T Stigbrand; A Ménez; M H Le Du
Journal:  J Biol Chem       Date:  2001-06-06       Impact factor: 5.157

6.  Childhood hypophosphatasia due to a de novo missense mutation in the tissue-nonspecific alkaline phosphatase gene.

Authors:  A Taillandier; S-L Sallinen; I Brun-Heath; P De Mazancourt; J-L Serre; E Mornet
Journal:  J Clin Endocrinol Metab       Date:  2005-01-25       Impact factor: 5.958

7.  Crystal structure of alkaline phosphatase from human placenta at 1.8 A resolution. Implication for a substrate specificity.

Authors:  M H Le Du; T Stigbrand; M J Taussig; A Menez; E A Stura
Journal:  J Biol Chem       Date:  2000-12-20       Impact factor: 5.157

8.  Kinetic characterization of hypophosphatasia mutations with physiological substrates.

Authors:  Sonia Di Mauro; Thomas Manes; Lovisa Hessle; Alexey Kozlenkov; João Martins Júnior Pizauro; Marc F Hoylaerts; Jose Luis Millán
Journal:  J Bone Miner Res       Date:  2002-08       Impact factor: 6.741

9.  Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization.

Authors:  Lovisa Hessle; Kristen A Johnson; H Clarke Anderson; Sonoko Narisawa; Adnan Sali; James W Goding; Robert Terkeltaub; José Luis Millan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-24       Impact factor: 11.205

Review 10.  Runx2/Cbfa1: a multifunctional regulator of bone formation.

Authors:  J B Lian; G S Stein
Journal:  Curr Pharm Des       Date:  2003       Impact factor: 3.116

View more
  4 in total

1.  Skeletal mineralization defects in adult hypophosphatasia--a clinical and histological analysis.

Authors:  F Barvencik; F Timo Beil; M Gebauer; B Busse; T Koehne; S Seitz; J Zustin; P Pogoda; T Schinke; M Amling
Journal:  Osteoporos Int       Date:  2011-01-26       Impact factor: 4.507

Review 2.  [Pathological and metabolic bone diseases: Clinical importance for fracture treatment].

Authors:  R Oheim
Journal:  Unfallchirurg       Date:  2015-12       Impact factor: 1.000

3.  Genome expression profiling and network analysis of nitrite therapy during chronic ischemia: possible mechanisms and interesting molecules.

Authors:  Christopher B Pattillo; Kai Fang; Sibile Pardue; Christopher G Kevil
Journal:  Nitric Oxide       Date:  2009-12-04       Impact factor: 4.427

Review 4.  Hypophosphatasia: From Diagnosis to Treatment.

Authors:  Sebastian Simon; Heinrich Resch; Klaus Klaushofer; Paul Roschger; Jochen Zwerina; Roland Kocijan
Journal:  Curr Rheumatol Rep       Date:  2018-09-10       Impact factor: 4.592

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.